These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 5539182)
1. Agglutinin response to pertussis vaccination in the child. Abbott JD; Preston NW; Mackay RI Br Med J; 1971 Jan; 1(5740):86-8. PubMed ID: 5539182 [TBL] [Abstract][Full Text] [Related]
2. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
3. [Immunological control of anti-pertussis vaccination]. Zalman MW; Gherman DN; Nicolau D Pediatria (Bucur); 1973; 22(2):121-7. PubMed ID: 4737187 [No Abstract] [Full Text] [Related]
4. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015 [TBL] [Abstract][Full Text] [Related]
5. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM Front Immunol; 2018; 9():51. PubMed ID: 29416544 [TBL] [Abstract][Full Text] [Related]
6. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763 [TBL] [Abstract][Full Text] [Related]
7. Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose. Vermeulen F; Dirix V; Verscheure V; Damis E; Vermeylen D; Locht C; Mascart F Vaccine; 2013 Apr; 31(15):1981-6. PubMed ID: 23429006 [TBL] [Abstract][Full Text] [Related]
8. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. van der Lee S; Sanders EAM; Berbers GAM; Buisman AM Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the immunogenic effect of pertussis vaccines]. JOO I; CSIZMAS L Gyermekgyogyaszat; 1956 Jan; 7(1):1-10. PubMed ID: 13294618 [No Abstract] [Full Text] [Related]
10. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085 [TBL] [Abstract][Full Text] [Related]
13. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK. Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304 [TBL] [Abstract][Full Text] [Related]
14. [BEHAVIOR OF THE ANTI-A AND ANTI-B AGGLUTININS IN CHILDREN AFTER VACCINATION WITH TRIPLE ANTIGENS (DIPHTHERIA, TETANUS, PERTUSSIS). II. AFTER 1 OR MORE BOOSTER INJECTIONS]. BARTOLOZZI G; PAVARI E; VIERUCCI A; MARIANELLI L Minerva Pediatr; 1964 Mar; 16():386-90. PubMed ID: 14143191 [No Abstract] [Full Text] [Related]
15. Efficacy of pertussis vaccines: a brighter horizon. Preston NW; Stanbridge TN Br Med J; 1972 Aug; 3(5824):448-51. PubMed ID: 4341645 [TBL] [Abstract][Full Text] [Related]
16. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age. Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640 [TBL] [Abstract][Full Text] [Related]
17. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126 [TBL] [Abstract][Full Text] [Related]
18. Protection against clinical pertussis induced by whole-cell pertussis vaccination is related to primo-immunisation intervals. Silfverdal SA; Ehlin A; Montgomery SM Vaccine; 2007 Oct; 25(43):7510-5. PubMed ID: 17905483 [TBL] [Abstract][Full Text] [Related]